Theravance Biopharma's directors, officers and employees are committed to integrity in everything we do. We are dedicated to lawful and ethical conduct throughout the company.
The Company will hold its 2017 Annual General Meeting of Shareholders on Wednesday May 17, 2017 in Dublin, Ireland. Further information regarding the Annual General Meeting will be provided in the Company’s proxy materials, which will be filed with the SEC and made available to shareholders prior to the Annual General Meeting.
|Audit Committee Charter|
|Compensation Committee Charter|
|Nominating and Governance Committee Charter|
|Science & Technology Advisory Committee Charter|
|Corporate Governance Guidelines|
|Code of Business Conduct|
|Amended and Restated Memorandum and Articles of Association|
|CA Declaration and Comprehensive Compliance Program|